Robbins Geller Looks To Lead Valeant Securities Fraud Suit
A teacher's retirement fund that alleges Valeant Pharmaceuticals fraudulently inflated its stock price, causing the fund to lose more than $90 million, asked a New Jersey federal court Monday to consolidate four...To view the full article, register now.
Already a subscriber? Click here to view full article